Cargando…
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
Mucositis is one of the most significant toxicities in cancer patients undergoing cytotoxic treatment. It can have a negative impact on both quality of life and health economics. Severe oral mucositis can contribute to hospitalization, need for narcotic analgesics, total parentral nutrition, subopti...
Autores principales: | Vadhan-Raj, Saroj, Goldberg, Jenna D, Perales, Miguel-Angel, Berger, Dietmar P, Brink, Marcel RM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117550/ https://www.ncbi.nlm.nih.gov/pubmed/24251854 http://dx.doi.org/10.1111/jcmm.12169 |
Ejemplares similares
-
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
por: Sonis, Stephen T
Publicado: (2010) -
Palifermin for management of treatment-induced oral mucositis in cancer patients
por: Barasch, Andrei, et al.
Publicado: (2009) -
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease
por: Kapoor, Shailendra
Publicado: (2012) -
Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case–control study
por: Lauritano, Dorina, et al.
Publicado: (2014) -
Efficacy of Palifermin in the Hematopoietic Stem Cell Transplant Setting
por: Panjwani, Muneera
Publicado: (2013)